Atlas Trials

Monitoring of Azathioprine Metabolite Concentrations and Cytokine Levels in Neuromyelitis Optica Spectrum Disorder

Clinical trial NCT05896605 · COMPLETED

Trial details

NCT number
NCT05896605
Sponsor
First Affiliated Hospital of Guangxi Medical University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
NMO Spectrum DisorderAzathioprine Adverse Reaction
Start date
2020-01-01
Primary completion
2022-12-31
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.